About Edip Gurol, MD
Dr. Edip Gurol is a stroke neurologist with particular expertise in the care of patients at high risk for ischemic (blockage type) strokes and hemorrhages. His NIH-funded research focuses on clarifying the mechanisms of brain small vessel diseases that increase the risk of both types of strokes. Dr. Gurol is an international expert in stroke prevention for patients with atrial fibrillation and high hemorrhagic risk.
1988 - 1994 | Medical School | Istanbul University Cerrahpasa Medical School |
1995 - 2002 | Internship, Residency, and Fellowship | Istanbul University, Istanbul Medical School Hospital Neurology, Stroke |
2003 - 2005 | Clinical Research | Massachusetts General Hospital Neurology, Clinical Trials Unit |
2005 - 2009 | Residency | University of Iowa Hospitals and Clinics Neurology |
2009 - 2010 2010 - | Fellowship Stroke Neurologist | Mass General Brigham / Massachusetts General / Brigham Women Stroke and Neurocritical care Massachusetts General Hospital Stroke Service |
Clinical Interests:
- Cerebral amyloid angiopathy (CAA)
- Intracerebral hemorrhage (brain bleeds)
- Ischemic stroke (brain infarcts)
- Stroke
- Stroke Prevention
Treats:
- Adult
Languages:
- French, Turkish
Locations
Mass General Vascular Center: Stroke Service
55 Fruit St.
Wang Ambulatory Care Center
7th Floor, Suite 720
Boston, MA 02114
Phone: 617-726-8459
Medical Education
- MD, Istanbul University School of Medicine
- Residency, Istanbul University School of Medicine
- Fellowship, Istanbul University School of Medicine
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Neurology, American Board of Psychiatry and Neurology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Structural and Functional Magnetic Resonance Imaging Predictors of Hemorrhage Recurrence and Disease Progression in Cerebral Amyloid Angiopathy
Molecular Mechanisms of Brain Injury in Patients with Age-Related Cerebral Small Vessel Diseases
Understanding embolic and hemorrhagic risk in patients with atrial fibrillation at risk of intracranial hemorrhage and determining the best management approaches (pharmacological vs nonpharmacological)
Publications
-
Gurol ME
Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk
Stroke. 2017; Dec 4. pii: STROKEAHA.117.017081. doi: 10.1161/STROKEAHA.117.017081. [Epub ahead of print]Gurol ME, Becker JA, Fotiadis P, Riley G, Schwab K, Johnson KA, Greenberg SM
Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study
Neurology. 2016 Nov 8;87(19):2043-2049Gurol ME
Molecular Neuroimaging in Vascular Cognitive Impairment
Stroke. 2016 Apr;47(4):1146-52Gurol ME, Greenberg SM
Management of intracerebral hemorrhage.
Curr Atheroscler Rep. 2008 Aug ; 10 (4): 324-31Gurol ME, Irizarry MC, Smith EE, Greenberg SM
Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.
Neurology. 2006 Jan 10; 66 (1): 23-9
Reviews: Comments and Ratings
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
HIV and Depression Clinical Trial
The Mukerji Lab for Neuroinfectious Diseases has an ongoing clinical trial for people with HIV and depression.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.